News about L'OREAL

  • Local
  • International
  • Company messages
07 Sep
24 Aug
01 Aug
01 Aug
26 Jul
05 Jul
20 Jun
08 Jun
31 May
29 May
28 May
25 May
21 May
15 May
15 May
07 May
03 May
02 May
17 Apr
17 Apr

Popular news

Teenager’s Lifesaving TickTracker App Recognized by Department of Health & Human Services
Pomerantz Law Firm Announces the Filing of a Class Action against OPKO Health, Inc. and Certain Officers – OPK
Novartis to file for new Lucentis® (ranibizumab) indication in retinopathy of prematurity (ROP), a rare disease in premature infants that often leads to blindness
InsurTech transactions reach new peak in Q2; 5-year Life & Health InsurTech investment exceeds $5 billion
Plexus Celebrates the Opening of the Enhanced Penang Design Center
New analysis of Novartis Phase III brolucizumab (RTH258) data reinforces superior reduction of retinal fluid, a key marker of disease activity in nAMD
Nightstar Reports Positive Proof of Concept Data from Dose Escalation Study in XIRIUS Trial for NSR-RPGR in XLRP Patients
CADWorx® & Analysis Solutions releases new CADWorx Design Review Professional for model visualization and publishing
Melinta Therapeutics Receives Positive CHMP Opinion for Vabomere™ (meropenem and vaborbactam)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Rockwell, GDS Holdings, and Zion and Encourages Investors to Contact the Firm

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
24 September 2018 09:00:37
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180919.1 - EUROWEB3 - 2018-09-24 10:00:37 - 2018-09-24 09:00:37 - 1000 - Website: OKAY